Variable renal atrial natriuretic factor gene expression in hypertension

Hypertension

Volumn 33, Issue 6, 1999, Pages 1342-1347

  Ogawa, Tsuneo ^a   Linz, Wolfgang ^b   Schölkens, Bernward A ^b   De Bold, Adolfo J ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b SANOFI   (France)

Author keywords

Atrial natriuretic factor; Deoxycorticosterone; Hypertension, renal; Kidney; Renin angiotensin system

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DEOXYCORTICOSTERONE ACETATE; MESSENGER RNA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEART; HYPERTENSION; KIDNEY; KIDNEY COLLECTING TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032977669     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.6.1342     Document Type: Article

References (26)

1. de Bold AJ, Bruneau BG, de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res. 1996;31:7-18.
2. Ogawa T, Bruneau BG, Yokota N, de Bold ML, de Bold AJ. Tissue-specific regulation of renal and cardiac atrial natriuretic factor gene expression in deoxycorticosterone acetate-salt rats. Hypertension. 1997; 30:1342-1347.
3. Yokota N, Bruneau BG, Fernandez BE, Kuroski de Bold ML, Piazza LA, Eid H, de Bold AJ. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats. Am J Hypertens. 1995;8:301-310.
4. Linz W, Schölkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens. 1989;11:1325-1350.
5. Ogawa T, Linz W, Stevenson M, Bruneau BG, Kuroski de Bold ML, Chen JH, Eid H, Schölkens BA, de Bold AJ. Evidence for load-dependant and load-independent determinants of cardiac natriuretic peptide production. Circulation. 1996;93:2059-2067.
6. Linz W, Schaper J, Wiemer G, Albus U, Schölkens BA. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br J Pharmacol. 1992;107:970-975.
7. Owens GK, Reidy MA. Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation. Circ Res. 1995;57:695-705.
8. Sarda IR, de Bold ML, de Bold AJ. Optimization of atrial natriuretic factor radioimmunoassay. Clin Biochem. 1989;22:11-15.
9. Burnham CE, Hawelu-Johnson CL, Frank BM, Lynch KR. Molecular cloning of rat renin cDNA and its gene. Proc Natl Acad Sci U S A. 1987;84:5605-5609.
10. Lynch KR, Simnad VI, Ben-Ari ET, Garrison JC. Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension. 1986;8:540-543.
11. Bernstein KE, Martin BM, Edwards AS, Bernstein EA. Mouse angiotensin-converting enzyme is a protein composed of two homologous domains. J Biol Chem. 1989;264:11945-11951.
12. Flynn TG, Davies PL, Kennedy BP, de Bold ML, de Bold AJ. Alignment of rat cardionatrin sequences with the preprocardionatrin sequence from complementary DNA. Science. 1985;228:323-325.
13. Mori N, Singer-Sam J, Lee CY, Riggs AD. The nucleotide sequence of a cDNA clone containing the entire coding region for mouse X-chromosome-linked phosphoglycerate kinase. Gene. 1986;45: 275-280.
14. Ingelfinger JR, Pratt RE, Ellison K, Dzau VJ. Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest. 1986;78:1311-1315.
15. el-Dahr SS, Dipp S, Guan S, Navar LG. Renin, angiotensinogen, and kallikrein gene expression in two-kidney Goldblatt hypertensive rats. Am J Hypertens. 1993;6:914-919.
16. Von Thun AM, el-Dahr SS, Vari RC, Navar G. Modulation of renin-angiotensin and kallikrein gene expression in experimental hypertension. Hypertension. 1994;23(suppl I):I-131-I-136.
17. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
18. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension. 1995;25:1252-1259.
19. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 1995;267:679-681.
20. Aviv R, Gurbanov K, Hoffman A, Blumberg S, Winaver J. Urinary neutral endopeptidase 24.11 activity: modulation by chronic salt loading. Kidney Int. 1995;47:855-860.
21. Hirata Y, Suzuki Y, Suzuki E, Hayakawa H, Kimura K, Goto A, Omata M, Minamino N, Kangawa K, Matsuo H. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors. J Hypertens. 1994;12:367-374.
22. Scott JM, Barclay PL, Shepperson NB. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats. Eur J Pharmacol. 1993;242:91-97.
23. Seymour AA, Asaad MM, Lanoce VM, Fennell SA, Cheung HS, Rogers WL. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure. Cardiovasc Res. 1993;27:1015-1023.
24. Pham I, el Amrani AI, Fournie-Zaluski MC, Corvol P, Roques B, Michel J-B. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats. J Cardiovasc Pharmacol. 1992; 20:847-857.
25. Seymour AA, Asaad MM, Abboa-Offei BE, Smith PL, Rogers WL. Sodium loads enhance the natriuretic responses to atrial natriuretic peptide and neutral endopeptidase inhibitors in conscious cynomolgus monkeys. Clin Exp Pharmacol Physiol. 1994;21:845-856.
26. Yokota N, Bruneau BG, Kuroski de Bold ML, de Bold AJ. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon: evidence for a guanylate cyclase-mediated pathway. J Clin Invest. 1994;94:1938-1946.